PDMR Dealing - Purchase Of Shares
On September 24, 2025, PureTech Health plc announced that several of its directors purchased ordinary shares in the market between September 22-23, 2025. Robert Lyne, Interim Chief Executive Officer, purchased 81,051 shares at GBP 1.23 per share. Sharon Barber-Lui, Interim Board Chair, acquired 65,250 shares at GBP 1.24 per share. Non-Executive Director John LaMattina bought 59,100 shares at GBP 1.25 per share, and Michele Holcomb, also a Non-Executive Director, purchased 29,239 shares at GBP 1.25 per share. In aggregate, the directors purchased 234,640 shares at a price of GBP 1.24 per share on the London Stock Exchange.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Robert Lyne Sharon Barber-Lui John LaMattina Michele Holcomb |
| 2 | Reason for the notification | |
| a) | Position/status | Robert Lyne - Interim Chief Executive Officer Sharon Barber-Lui - Interim Board Chair; Non-Executive Director John LaMattina - Non-Executive Director Michele Holcomb - Non-Executive Director |
| b) | Initial notification/Amendment | Initial notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of PureTech Health plc ISIN GB00BY2Z0H74 |
| b) | Nature of the transaction | Purchase of shares in market |
| c) | Price(s) and volume(s) | Name Price(s) Volume(s) Robert Lyne GBP 1.23 per share 81,051 Sharon Barber-Lui GBP 1.24 per share 65,250 John LaMattina GBP 1.25 per share 59,100 Michele Holcomb GBP 1.25 per share 29,239 |
| d) | Aggregated information - Aggregated volume - Price | Price Aggregate Volume GBP 1.24 per share 234,640 |
| e) | Date of the transaction | 22-23 September 2025 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.